A clinical study for evaluating the safety of excessive consumption of saw palmetto extract. - A clinical study for evaluating the safety of excessive consumption of saw palmetto extract.

Oneness support Co., Ltd.0 个研究点目标入组 22 人开始时间: 2019年10月2日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Subjects who were diagnosed with serious disease (e.g., liver disease, kidney disease, digestive disease, heart disease, and/or peripheral vascular disease). (2) Subjects with abnormal parameters in liver and/or kidney function. (3) Subjects who had a gastrointestinal surgery. (4) Subjects with a disease currently under treatment. (5) Subjects with anemic. (6) Subjects who play high intensity sports and/or are on a diet. (7) Subjects who can't stop using functional foods (including Food for Specified Health Uses or Foods with Function Claims) and/or Specified quasi-drugs during the current study periods. (8) Subjects who are under treatment with medications (including OTC or prescribed medication). (9) Subjects who drink excessive alcohol, or who can't stop drinking from one day before each measurement. (10) Subjects who are planning to become pregnant after imformed consent for the current study, pregnant or lactating. (11) Subjects who are participating in other studies or planning to participate during the current study period. (12) Subjects who are judged as unsuitable for the current study by the investigator for other reasons.

发起方

Oneness support Co., Ltd.